NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD
1.12
+0.04 (+3.7%)
The current stock price of TNON is 1.12 USD. In the past month the price increased by 0.9%. In the past year, price decreased by -80.9%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.4 | 227.16B | ||
ISRG | INTUITIVE SURGICAL INC | 65.86 | 172.95B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.9 | 140.69B | ||
SYK | STRYKER CORP | 28.42 | 132.26B | ||
MDT | MEDTRONIC PLC | 15.47 | 105.94B | ||
BDX | BECTON DICKINSON AND CO | 14.29 | 57.06B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.3 | 42.05B | ||
IDXX | IDEXX LABORATORIES INC | 36.58 | 33.35B | ||
RMD | RESMED INC | 24.08 | 31.27B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 13.89 | 28.52B | ||
DXCM | DEXCOM INC | 41.56 | 26.89B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.04 | 22.19B |
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 21 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The firm has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
TENON MEDICAL INC
104 Cooper Ct.
Los Gatos CALIFORNIA US
Employees: 21
Company Website: https://www.tenonmed.com/
Investor Relations: http://ir.tenonmed.com/
Phone: 14086495760
The current stock price of TNON is 1.12 USD. The price increased by 3.7% in the last trading session.
The exchange symbol of TENON MEDICAL INC is TNON and it is listed on the Nasdaq exchange.
TNON stock is listed on the Nasdaq exchange.
8 analysts have analysed TNON and the average price target is 7.65 USD. This implies a price increase of 583.04% is expected in the next year compared to the current price of 1.12. Check the TENON MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
TENON MEDICAL INC (TNON) has a market capitalization of 6.94M USD. This makes TNON a Nano Cap stock.
TENON MEDICAL INC (TNON) currently has 21 employees.
TENON MEDICAL INC (TNON) has a support level at 0.98 and a resistance level at 1.13. Check the full technical report for a detailed analysis of TNON support and resistance levels.
The Revenue of TENON MEDICAL INC (TNON) is expected to grow by 89.23% in the next year. Check the estimates tab for more information on the TNON EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TNON does not pay a dividend.
TENON MEDICAL INC (TNON) will report earnings on 2025-05-12, after the market close.
TENON MEDICAL INC (TNON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-24.33).
The outstanding short interest for TENON MEDICAL INC (TNON) is 5.38% of its float. Check the ownership tab for more information on the TNON short interest.
ChartMill assigns a technical rating of 1 / 10 to TNON. When comparing the yearly performance of all stocks, TNON is a bad performer in the overall market: 94.99% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to TNON. The financial health of TNON is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months TNON reported a non-GAAP Earnings per Share(EPS) of -24.33. The EPS increased by 68.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -138.91% | ||
ROE | -228.99% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to TNON. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 82.01% and a revenue growth 89.23% for TNON